GE HEALTHCARE TECHNOLOGY (GEHC) Stock Fundamental Analysis

NASDAQ:GEHC • US36266G1076

80.16 USD
-4.11 (-4.88%)
At close: Mar 2, 2026
78.98 USD
-1.18 (-1.47%)
Pre-Market: 3/3/2026, 4:54:18 AM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to GEHC. GEHC was compared to 184 industry peers in the Health Care Equipment & Supplies industry. While GEHC belongs to the best of the industry regarding profitability, there are concerns on its financial health. GEHC is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • GEHC had positive earnings in the past year.
  • GEHC had a positive operating cash flow in the past year.
  • In the past 5 years GEHC has always been profitable.
  • Each year in the past 5 years GEHC had a positive operating cash flow.
GEHC Yearly Net Income VS EBIT VS OCF VS FCFGEHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.65%, GEHC belongs to the top of the industry, outperforming 83.70% of the companies in the same industry.
  • The Return On Equity of GEHC (20.09%) is better than 94.57% of its industry peers.
  • GEHC has a Return On Invested Capital of 7.81%. This is amongst the best in the industry. GEHC outperforms 83.15% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for GEHC is in line with the industry average of 8.75%.
Industry RankSector Rank
ROA 5.65%
ROE 20.09%
ROIC 7.81%
ROA(3y)5.31%
ROA(5y)6.29%
ROE(3y)21.03%
ROE(5y)19.41%
ROIC(3y)8.25%
ROIC(5y)9.14%
GEHC Yearly ROA, ROE, ROICGEHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • GEHC has a Profit Margin of 10.11%. This is amongst the best in the industry. GEHC outperforms 84.24% of its industry peers.
  • GEHC's Profit Margin has declined in the last couple of years.
  • GEHC's Operating Margin of 13.40% is amongst the best of the industry. GEHC outperforms 81.52% of its industry peers.
  • In the last couple of years the Operating Margin of GEHC has declined.
  • The Gross Margin of GEHC (39.98%) is worse than 67.39% of its industry peers.
  • In the last couple of years the Gross Margin of GEHC has remained more or less at the same level.
Industry RankSector Rank
OM 13.4%
PM (TTM) 10.11%
GM 39.98%
OM growth 3Y-0.87%
OM growth 5Y-3.3%
PM growth 3Y-1.1%
PM growth 5Y-34%
GM growth 3Y0.71%
GM growth 5Y0.28%
GEHC Yearly Profit, Operating, Gross MarginsGEHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GEHC is destroying value.
  • The number of shares outstanding for GEHC has been reduced compared to 1 year ago.
  • Compared to 5 years ago, GEHC has more shares outstanding
  • GEHC has about the same debt/assets ratio as last year.
GEHC Yearly Shares OutstandingGEHC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
GEHC Yearly Total Debt VS Total AssetsGEHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 1.94 indicates that GEHC is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • GEHC has a Altman-Z score of 1.94. This is comparable to the rest of the industry: GEHC outperforms 57.61% of its industry peers.
  • The Debt to FCF ratio of GEHC is 6.67, which is on the high side as it means it would take GEHC, 6.67 years of fcf income to pay off all of its debts.
  • GEHC's Debt to FCF ratio of 6.67 is fine compared to the rest of the industry. GEHC outperforms 75.54% of its industry peers.
  • A Debt/Equity ratio of 0.92 indicates that GEHC is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.92, GEHC is doing worse than 73.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 6.67
Altman-Z 1.94
ROIC/WACC0.8
WACC9.75%
GEHC Yearly LT Debt VS Equity VS FCFGEHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • GEHC has a Current Ratio of 1.37. This is a normal value and indicates that GEHC is financially healthy and should not expect problems in meeting its short term obligations.
  • GEHC has a worse Current ratio (1.37) than 78.26% of its industry peers.
  • A Quick Ratio of 1.13 indicates that GEHC should not have too much problems paying its short term obligations.
  • GEHC's Quick ratio of 1.13 is on the low side compared to the rest of the industry. GEHC is outperformed by 73.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.13
GEHC Yearly Current Assets VS Current LiabilitesGEHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 2.00% over the past year.
  • Measured over the past years, GEHC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -31.63% on average per year.
  • The Revenue has been growing slightly by 4.85% in the past year.
  • GEHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.74% yearly.
EPS 1Y (TTM)2%
EPS 3Y2.54%
EPS 5Y-31.63%
EPS Q2Q%-0.69%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y3.99%
Revenue growth 5Y3.74%
Sales Q2Q%7.13%

3.2 Future

  • GEHC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.96% yearly.
  • GEHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.10% yearly.
EPS Next Y9.67%
EPS Next 2Y10.7%
EPS Next 3Y10.13%
EPS Next 5Y8.96%
Revenue Next Year5.57%
Revenue Next 2Y5.05%
Revenue Next 3Y4.96%
Revenue Next 5Y3.1%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
GEHC Yearly Revenue VS EstimatesGEHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
GEHC Yearly EPS VS EstimatesGEHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.50 indicates a rather expensive valuation of GEHC.
  • 88.04% of the companies in the same industry are more expensive than GEHC, based on the Price/Earnings ratio.
  • GEHC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.13.
  • GEHC is valuated correctly with a Price/Forward Earnings ratio of 15.96.
  • Based on the Price/Forward Earnings ratio, GEHC is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.11, GEHC is valued a bit cheaper.
Industry RankSector Rank
PE 17.5
Fwd PE 15.96
GEHC Price Earnings VS Forward Price EarningsGEHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 85.87% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 84.78% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 24.27
EV/EBITDA 12.6
GEHC Per share dataGEHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GEHC does not grow enough to justify the current Price/Earnings ratio.
  • GEHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.81
PEG (5Y)N/A
EPS Next 2Y10.7%
EPS Next 3Y10.13%

3

5. Dividend

5.1 Amount

  • GEHC has a yearly dividend return of 0.17%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.20, GEHC pays a better dividend. On top of this GEHC pays more dividend than 89.67% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, GEHC's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.17%

5.2 History

  • GEHC has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
GEHC Yearly Dividends per shareGEHC Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • GEHC pays out 3.07% of its income as dividend. This is a sustainable payout ratio.
DP3.07%
EPS Next 2Y10.7%
EPS Next 3Y10.13%
GEHC Yearly Income VS Free CF VS DividendGEHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
GEHC Dividend Payout.GEHC Dividend Payout, showing the Payout Ratio.GEHC Dividend Payout.PayoutRetained Earnings

GE HEALTHCARE TECHNOLOGY

NASDAQ:GEHC (3/2/2026, 8:23:49 PM)

Premarket: 78.98 -1.18 (-1.47%)

80.16

-4.11 (-4.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-04
Earnings (Next)04-27
Inst Owners89.01%
Inst Owner Change3.56%
Ins Owners0.28%
Ins Owner Change0.27%
Market Cap36.53B
Revenue(TTM)20.63B
Net Income(TTM)2.08B
Analysts78.57
Price Target95.29 (18.87%)
Short Float %2.2%
Short Ratio3.04
Dividend
Industry RankSector Rank
Dividend Yield 0.17%
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP3.07%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.4%
Min EPS beat(2)-0.16%
Max EPS beat(2)0.96%
EPS beat(4)3
Avg EPS beat(4)5.61%
Min EPS beat(4)-0.16%
Max EPS beat(4)13.24%
EPS beat(8)6
Avg EPS beat(8)4.83%
EPS beat(12)10
Avg EPS beat(12)5.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.59%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)-0.44%
Revenue beat(4)1
Avg Revenue beat(4)-0.46%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)0.42%
Revenue beat(8)1
Avg Revenue beat(8)-1.72%
Revenue beat(12)2
Avg Revenue beat(12)-1.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.85%
PT rev (3m)6.38%
EPS NQ rev (1m)6.22%
EPS NQ rev (3m)4.69%
EPS NY rev (1m)-0.23%
EPS NY rev (3m)-0.37%
Revenue NQ rev (1m)0.61%
Revenue NQ rev (3m)0.61%
Revenue NY rev (1m)1.18%
Revenue NY rev (3m)1.09%
Valuation
Industry RankSector Rank
PE 17.5
Fwd PE 15.96
P/S 1.77
P/FCF 24.27
P/OCF 18.39
P/B 3.52
P/tB N/A
EV/EBITDA 12.6
EPS(TTM)4.58
EY5.71%
EPS(NY)5.02
Fwd EY6.27%
FCF(TTM)3.3
FCFY4.12%
OCF(TTM)4.36
OCFY5.44%
SpS45.26
BVpS22.77
TBVpS-9.3
PEG (NY)1.81
PEG (5Y)N/A
Graham Number48.44
Profitability
Industry RankSector Rank
ROA 5.65%
ROE 20.09%
ROCE 9.94%
ROIC 7.81%
ROICexc 9.32%
ROICexgc 25%
OM 13.4%
PM (TTM) 10.11%
GM 39.98%
FCFM 7.3%
ROA(3y)5.31%
ROA(5y)6.29%
ROE(3y)21.03%
ROE(5y)19.41%
ROIC(3y)8.25%
ROIC(5y)9.14%
ROICexc(3y)9.48%
ROICexc(5y)10.1%
ROICexgc(3y)28.41%
ROICexgc(5y)36.05%
ROCE(3y)10.49%
ROCE(5y)11.63%
ROICexgc growth 3Y-16.74%
ROICexgc growth 5Y-17.72%
ROICexc growth 3Y-3.85%
ROICexc growth 5Y-6.16%
OM growth 3Y-0.87%
OM growth 5Y-3.3%
PM growth 3Y-1.1%
PM growth 5Y-34%
GM growth 3Y0.71%
GM growth 5Y0.28%
F-Score4
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 6.67
Debt/EBITDA 2.85
Cap/Depr 83.39%
Cap/Sales 2.34%
Interest Coverage 5.29
Cash Conversion 59.47%
Profit Quality 72.18%
Current Ratio 1.37
Quick Ratio 1.13
Altman-Z 1.94
F-Score4
WACC9.75%
ROIC/WACC0.8
Cap/Depr(3y)71.99%
Cap/Depr(5y)60.92%
Cap/Sales(3y)2.12%
Cap/Sales(5y)1.89%
Profit Quality(3y)91.25%
Profit Quality(5y)85.67%
High Growth Momentum
Growth
EPS 1Y (TTM)2%
EPS 3Y2.54%
EPS 5Y-31.63%
EPS Q2Q%-0.69%
EPS Next Y9.67%
EPS Next 2Y10.7%
EPS Next 3Y10.13%
EPS Next 5Y8.96%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y3.99%
Revenue growth 5Y3.74%
Sales Q2Q%7.13%
Revenue Next Year5.57%
Revenue Next 2Y5.05%
Revenue Next 3Y4.96%
Revenue Next 5Y3.1%
EBIT growth 1Y5.26%
EBIT growth 3Y3.09%
EBIT growth 5Y0.31%
EBIT Next Year31.3%
EBIT Next 3Y14.92%
EBIT Next 5Y12.25%
FCF growth 1Y-2.9%
FCF growth 3Y-5.84%
FCF growth 5Y-8.6%
OCF growth 1Y1.85%
OCF growth 3Y-2.03%
OCF growth 5Y-5.37%

GE HEALTHCARE TECHNOLOGY / GEHC FAQ

What is the fundamental rating for GEHC stock?

ChartMill assigns a fundamental rating of 5 / 10 to GEHC.


What is the valuation status for GEHC stock?

ChartMill assigns a valuation rating of 6 / 10 to GE HEALTHCARE TECHNOLOGY (GEHC). This can be considered as Fairly Valued.


How profitable is GE HEALTHCARE TECHNOLOGY (GEHC) stock?

GE HEALTHCARE TECHNOLOGY (GEHC) has a profitability rating of 7 / 10.


What is the financial health of GE HEALTHCARE TECHNOLOGY (GEHC) stock?

The financial health rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10.


Can you provide the dividend sustainability for GEHC stock?

The dividend rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10 and the dividend payout ratio is 3.07%.